Menu
Search
|

Menu

Close
X

Insulet Corp PODD.OQ (NASDAQ Stock Exchange Global Select Market)

148.04 USD
-0.00 (-0.00%)
As of Sep 18
Previous Close 148.04
Open 144.97
Volume 182,698
3m Avg Volume 204,848
Today’s High 148.64
Today’s Low 143.75
52 Week High 168.00
52 Week Low 70.82
Shares Outstanding (mil) 59.68
Market Capitalization (mil) 7,465.97
Forward P/E 578.86
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.78 Mean rating from 18 analysts

KEY STATS

Revenue (mm, USD)
FY19
160
FY18
564
FY17
464
FY16
367
EPS (USD)
FY19
0.072
FY18
0.032
FY17
-0.458
FY16
-0.475
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
578.86
33.85
Price to Sales (TTM)
vs sector
12.45
7.90
Price to Book (MRQ)
vs sector
33.36
4.38
Price to Cash Flow (TTM)
vs sector
237.03
23.70
Total Debt to Equity (MRQ)
vs sector
268.12
17.64
LT Debt to Equity (MRQ)
vs sector
268.12
12.61
Return on Investment (TTM)
vs sector
1.80
12.69
Return on Equity (TTM)
vs sector
7.22
17.13

EXECUTIVE LEADERSHIP

Timothy Scannell
Chairman of the Board, Since 2019
Salary: --
Bonus: --
Shacey Petrovic
President, Chief Executive Officer, Director, Since 2019
Salary: $542,308.00
Bonus: $855,000.00
Wayde McMillan
Chief Financial Officer, Executive Vice President, Since 2019
Salary: --
Bonus: --
Charles Alpuche
Chief Operating Officer, Executive Vice President, Since 2018
Salary: $390,769.00
Bonus: $467,000.00
Aiman Abdel-Malek
Executive Vice President, Chief Technology Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

100 Nagog Park
ACTON   MA   01720-3440

Phone: +1978.6007000

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

SPONSORED STORIES